UC Davis

Respira Labs, Inc. is a company focused on developing innovative solutions for managing chronic obstructive pulmonary disease (COPD). Based in Mountain View, California, the company has created Sylvee, a wearable device that utilizes advanced technology to continuously monitor lung function and predict COPD exacerbation attacks in real-time. This device is equipped with non-invasive acoustic sensors and employs techniques such as audio signal processing and machine learning to detect "trapped air," an early indicator of potential COPD issues. By enabling early intervention and prevention of exacerbations, Respira Labs aims to enhance patient quality of life and health outcomes while also reducing healthcare costs. Founded in 2018, the company is positioned to transform the landscape of COPD management through its innovative approach.

ARIZ Precision Medicine Inc. is a biotechnology company focused on researching and developing innovative drug candidates for various types of cancer, including lung, breast, colon, myeloma, leukemia, prostate, liver, and lymphoma. Founded in 2015 and headquartered in Davis, California, the company employs a unique methodology that breaks down the complexities of cancer into smaller, manageable problems. This approach allows ARIZ to design targeted therapies that address the underlying causes of cancer while ensuring that drugs are delivered directly to cancer cells, minimizing damage to surrounding healthy tissue. By concentrating its efforts on precision medicine, ARIZ aims to provide healthcare professionals with effective new treatments tailored to individual cancer profiles.